Clinical Trial Update: APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study [NA]

View source ↗

Summary

This entry reports a two-part, open-label, non-randomized multicenter clinical trial evaluating a VOIS vocal cord implant for unilateral vocal cord paralysis. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unilateral Vocal Cord Paralysis

Snippet

Sponsor: APrevent Biotech GmbH | Conditions: Paralysis, Unilateral, Vocal Cord | NA | Status: RECRUITING